Search Login Register

aripiprazole (Abilify) Summary

Description: has both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity; structure given in first source; use associated with HYPERGLYCEMIA

Also Known As: Abilify; 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone; Bristol-Myers Squibb brand of aripiprazole; OPC 14597; OPC-14597 Show All >>

Networked: 1439 relevant articles (300 outcomes, 458 trials/studies) for this Drug

Key Diseases for which aripiprazole is Relevant

  1. Schizophrenia (Dementia Praecox) : 108 outcomes 199 studies in 514 results
  2. Bipolar Disorder (Mania) : 56 outcomes 76 studies in 205 results
  3. Psychotic Disorders (Schizoaffective Disorder) : 25 outcomes 46 studies in 112 results
  4. Major Depressive Disorder (Major Depressive Disorders) : 24 outcomes 38 studies in 85 results
  5. Movement Disorders (Movement Disorder) : 17 outcomes 6 studies in 59 results
Show All >>

Drugs Related to aripiprazole

  1. Risperidone (Risperdal Consta)
  2. olanzapine (Zyprexa)
  3. Antipsychotic Agents (Antipsychotics)
  4. quetiapine (Seroquel)
  5. Haloperidol (Haldol)
  6. ziprasidone (Geodon)
  7. Clozapine (Clozaril)
  8. Lithium
  9. Valproic Acid (Valproate, Semisodium)
  10. Dopamine (Intropin)
Show All >>

Therapies Related to aripiprazole

  1. Drug Therapy (Chemotherapy)
  2. Injections
  3. Stents
  4. Intramuscular Injections
  5. Patient Readmission
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.